Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [349]
News [2059]
Articles [63]
Editorials [3]
Conferences [71]
elearning [14]
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
What's new for ipilimumab? Report from ESMO 2010
What's new for ipilimumab? Report from ESMO 2010
Denosumab update from ESMO 2010
Denosumab update from ESMO 2010
ESMO 35: Pazopanib shows promise in Phase-II trial for relapse/refractory urothelial cancer
ESMO 35: Pazopanib shows promise in Phase-II trial for relapse/refractory urothelial cancer
ESMO 35: Phase III study shows everolimus delays tumour progression in hard-to-treat neuroendocrine tumours
ESMO 35: Phase III study shows everolimus delays tumour progression in hard-to-treat neuroendocrine tumours
ESMO 35: Most Italian breast cancer patients older, and diagnosed very early
ESMO 35: Most Italian breast cancer patients older, and diagnosed very early
ECCO PAC/eurocancercoms roundtable
ECCO PAC/eurocancercoms roundtable
ESMO Session: Melanoma
ESMO Session: Melanoma
Latest news from EMSO for Avastin (bevacizumab)
Latest news from EMSO for Avastin (bevacizumab)
ESMO 35: Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
ESMO 35: Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation